Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ‘self-destruct’ ...
Morning Overview on MSN
Stem cell breakthrough may restore hearing loss
Recent advancements in stem cell therapy are paving the way for potential breakthroughs in reversing hearing loss. This ...
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...
4d
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and ...
Ramona’s Vireo platform is recognized in the 2025 Top Innovations Startup category for its unique multi-camera microscope ...
MedPage Today on MSN
T-Cell Killer Opens New Approach to Rheumatoid Arthritis
Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback